Citadel Advisors’s Diebold Nixdorf DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
MCM
Citadel Advisors's DBD Position: Q2 2026 in Review
Citadel Advisors reduced its Diebold Nixdorf (DBD) stake by 98% in Q2 2026, selling an estimated $8.87M and leaving 2,717 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #11730.
Citadel Advisors first reported a position in DBD in Q3 2023 and has held it in 10 quarters since. The position peaked at $8.53M in Q1 2026. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.
- Citadel Advisors held 2,717 shares of Diebold Nixdorf worth $231K as of Q2 2026.
- Citadel Advisors sold 110,354 Diebold Nixdorf shares in Q2 2026, an estimated $8.87M.
- Diebold Nixdorf made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11730 holding.
- Citadel Advisors first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 10 quarters since.
- Citadel Advisors's Diebold Nixdorf position peaked at $8.53M in Q1 2026.
- 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.